CXCL13:免疫媒介炎症疾病的常见目标
Lu Hui1, Ye Li1, Meng-Ke Huang1
1Department of Laboratory Medicine, West China Second University Hospital, and Key Laboratory of Obstetric and Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Sichuan University, No. 20, Section 3, Renmin Road South, Chengdu, 610041, Sichuan, People's Republic of China.
Clinical and experimental medicine
|October 23, 2024
概括
化学物质CXCL13调节淋巴细胞器官发育和免疫反应. 它在疾病中的异位表达驱动着炎症和异位淋巴体结构,提供治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- CXCL13是一种化学激素,对二次淋巴细胞器官发育至关重要.
- 它的作用扩展到调节各种疾病中的炎症反应.
- 在健康状态和疾病状态之间,CXCL13的表达有所不同.
研究的目的:
- 在不同的生理和病理条件下审查CXCL13的来源.
- 阐明CXCL13在免疫媒介炎症疾病中的调节机制.
- 为在疾病治疗中针对CXCL13提供见解.
主要方法:
- 文献综述侧重于CXCL13的表达和功能.
- 对健康与患病宿主中CXCL13来源的分析.
- 检查CXCL13在免疫细胞迁移和宫外淋巴细胞器官生成中的作用.
主要成果:
- 在健康情况下,CXCL13是由肌细胞/毛囊T细胞产生,在疾病中,由外周T细胞/巨细胞异位产生.
- 宫外CXCL13表达促进免疫细胞透和炎症因子的产生.
- 宫外CXCL13是宫外淋巴细胞结构形成的关键驱动因素.
结论:
- 了解CXCL13的来源和调节对于免疫媒介炎症疾病至关重要.
- 针对子宫外CXCL13提供了一个潜在的治疗策略.
- 对CXCL13机制的进一步研究可能会导致新的治疗方法.
相关概念视频
T Cell Types and Functions
955
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
955
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


